ATLANTA, Ga., July 10, 2000 (PRIMEZONE) -- Mr. Altaf Nazerali, President & CEO of Intacta Technologies Inc., is pleased to announce that Dr. Marty Singer has been appointed as an advisor to the Company. Dr. Singer is currently President and CEO of SAFCO Technologies, Inc. (STI), a wholly owned subsidiary of Salient 3 Communications, Inc.
Before joining STI, Dr. Singer held senior engineering and business management positions at Motorola, Tellabs, Bell Laboratories, and AT & T, and academic positions at the University of Denver and the University of Delaware. While at Motorola, he was Vice President and General Manager of the Wireless Local Loop Division within their Cellular Infrastructure Group. He currently serves on the Board of Overseers at the Illinois Institute of Technology, is a member of the Boards of Directors of PC-Tel and Global Business Network, and is a Vice President of the America-Israel Chamber of Commerce and Industry.
"Marty will assist Intacta in negotiating potential licensing arrangements for its patented technology in the wireless and telecommunications sector," said Mr. Nazerali. "Our IntactaCode (tm) software provides exceptional bandwidth compression, error correction, and encoding solutions and Marty's global expertise in licensing and business development will assist Intacta in developing relationships in the telecommunications industry."
Dr. Singer earned his M.A. and Ph.D. in Experimental Psychology at Vanderbilt University. He earned his B.A. in Psychology at the University of Michigan. He has been awarded five U.S. patents in telephony and has published articles on topics ranging from hybrid networks, wireless in the local loop (WiLL), and cellular fraud, to social issues impacted by telecommunications. He has negotiated significant licensing arrangements with the European GSM infrastructure vendors, Qualcomm, and Motorola.
About Intacta Technologies Inc.
INTACTA (OTCBB:ITAC) is a U.S. based software company headquartered in Atlanta, Georgia with its research and development facilities in Beer Sheva, Israel. The Company develops and markets software components designed to bridge enterprise communications and information management systems across digital and non-digital mediums. Intacta.Code(tm), the company's flagship product, is an award winning technology patented in the United States, Israel, and Europe. Platform transparent, and language transparent, Intacta.Code is designed to integrate with existing enterprise communications and information management systems requiring enhancements to security, transmission, and device handling on any number of handheld platforms, including Windows CE, WAP, and Palm OS. Intacta licenses its Intacta.Code to developers and system integrators, either as a stand-alone module or as an SDK for seamless and transparent integration within any application.
Intacta and Intacta.Code are trademarks of the Company. All other company/product names mentioned may be trademarks or registered trademarks of their respective holders and are used for identification purpose only.
Safe Harbor Statement Under the Private Securities Litigation Reform Act of 1995: Certain statements contained in this news release constitute "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, including statements regarding Dr. Singer's role in negotiating potential licensing arrangements and assisting Intacta in developing relationships in the telecommunications industry. These forward-looking statements involve a number of known and unknown risks, uncertainties and other factors, which may cause the actual results, performance or achievements of the Company to be materially different from any future results, performance or achievements expressed or implied by these forward-looking statements. These factors include, but are not limited to, risks relating to Dr. Singer's ability to successfully negotiate licensing arrangements and develop relationships in the telecommunications industry and Dr. Singer's continued interest and commitment in serving as an advisor to the Company. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date the statement was made.
-0- For more information, contact: Sandra Buschau, Investor Relations sandy@ipm.bc.ca Tel: (604) 684-4691 Investor Relations Contact Sandra Buschau Tel: (604) 684-4691 E-mail: sandy@ipm.bc.ca